SCHEMBL26430962

SCHEMBL26430962

O=[N+]([O-])c1ccccc1-c1ccc(Cl)c2c1oc1ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.50
▸ LMNA P02545 2/20 0.50
▸ MEN1 O00255 5/20 0.43
▸ KMT2A Q03164 5/20 0.43
▸ MAPT P10636 5/20 0.43
▸ F2 P00734 1/20 0.43
▸ C1R P00736 1/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ GABRP O00591 1/20 0.40
▸ GABRD O14764 1/20 0.40
▸ GABRA1 P14867 1/20 0.40
▸ GABRB1 P18505 1/20 0.40
▸ GABRG2 P18507 1/20 0.40
▸ GABRB3 P28472 1/20 0.40
▸ GABRA5 P31644 1/20 0.40
▸ GABRA3 P34903 1/20 0.40
▸ GABRA2 P47869 1/20 0.40
▸ GABRB2 P47870 1/20 0.40
▸ GABRA4 P48169 1/20 0.40
▸ GABRE P78334 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL782755 0.80 ALDH1A1 (0.57) ALDH1A1LMNAMEN1KMT2AMAPT
SCHEMBL29506802 0.80 ALDH1A1 (0.57) ALDH1A1LMNAMEN1KMT2AMAPT
SCHEMBL16276010 0.80 ALDH1A1 (0.54) ALDH1A1LMNAMEN1KMT2AMAPT
SCHEMBL17406614 0.79 ALDH1A1 (0.50) ALDH1A1LMNAMEN1KMT2AMAPT
SCHEMBL18086411 0.79 ALDH1A1 (0.53) ALDH1A1LMNAMEN1KMT2AMAPT
SCHEMBL17406610 0.79 ALDH1A1 (0.50) ALDH1A1LMNAMEN1KMT2AMAPT
SCHEMBL17406612 0.79 LMNA (0.43) ALDH1A1LMNAMEN1KMT2AMAPT
SCHEMBL17706811 0.79 ALDH1A1 (0.58) ALDH1A1LMNAMEN1KMT2AMAPT
SCHEMBL18810941 0.77 ALDH1A1 (0.52) ALDH1A1LMNAMEN1KMT2AMAPT
SCHEMBL19863146 0.76 ALDH1A1 (0.53) ALDH1A1LMNAMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230130126-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME LT MATERIALS CO., LTD. (KR) 2023-04-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230130126-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, PER2, CRY2 ALDH1A1 1355/4885LMNA 2019/4885MEN1 3166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback